Skip to search formSkip to main contentSkip to account menu

Myfortic Pill

National Institutes of Health

Related topics

Related topics

3 relations

Narrower (1)

Mycophenolic Acid 360 MG Delayed Release Oral Tablet [Myfortic]
MyforticPills

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Anémie hémolytique auto-immune : expérience de deux services de médecine interne
2013
2013
The changing face of donation in the UK: kidney donation after circulatory death
Affiliated to the Association of Surgeons in Training and the British Transplantation Society, the Carrel Club is the transplant… 
2013
2013
Advagraf® and Myfortic® in combination are associated with fewer gastrointestinal symptoms in kidney transplant recipients
Affiliated to the Association of Surgeons in Training and the British Transplantation Society, the Carrel Club is the transplant… 
2010
2010
EARLY OUTCOME ANALYSIS OF THE MYCOPHENOLIC ACID OBSERVATIONAL RENAL TRANSPLANT (MORE) REGISTRY: INITIAL COMPARISONS OF EC-MPS (MYFORTIC®) AND MMF (CELLCEPT®).: 2197
2007
2007
Ulcérations buccales après prise de mycophénolate de sodium (Myfortic
2006
2006
Complete Resolution of Severe Diarrhoea after Conversion from Mycophenolate Mofetil to Enteric-coated Mycophenolate Sodium (myfortic®) in a Patient at High Immunological Risk
The patient, a 49-year-old man, was diagnosed with end-stage renal failure as a result of chronic glomerulonephritis in 1986… 
2006
2006
Resolution of Gastrointestinal Side Effects in a Patient Converted from Mycophenolate Mofetil to Enteric-coated Mycophenolate Sodium (myfortic®)
A 25-year-old man with chronic renal failure as a result of membranoproliferative glomerulonephritis with horseshoe kidneys… 
2006
2006
Resolution of Severe Diarrhoea and Return to Work in a Patient Converted from Mycophenolate Mofetil to Enteric-coated Mycophenolate Sodium (myfortic®)
A male patient underwent renal transplantation in March 1995 at the age of 44 years, for chronic kidney disease of unknown… 
2006
2006
Resolution of Severe Anaemia and Hypotension Secondary to Rectal Ulcers in a Renal Transplant Patient after Conversion from Mycophenolate Mofetil to Enteric-coated Mycophenolate Sodium (myfortic®)
The patient was a 47-year-old man who developed end-stage renal disease as a result of vascular nephropathy (nephrosclerosis). He… 
2006
2006
Improvement in Social Functioning in Kidney Transplant Patients after Conversion from Mycophenolate Mofetil to Enteric-coated Mycophenolate Sodium (myfortic®): Three Case Studies
The patient was a 61-year-old Caucasian woman who had suffered from Wegener’s granulomatosis for 4 years, requiring haemodialysis… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)